CRSP
CRISPR Therapeutics AG · Healthcare
CEO Samarth Kulkarni sold $1.2M of CRISPR Therapeutics AG
Sold$1,206,243
$48.25Price
25,000Shares
−6%Stake
What CRSP did after the filing
- The stock from Wed, Mar 1 close, $47.72
- +6.0%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Apr 13 close.
Traded Mon, Feb 27. Filed Wed, Mar 1, 1:11 PM ET, during the session. Returns use the Mar 1 close and the Apr 13 close. Not investment advice.